t2cure
Frankfurt
About t2cure
t2cure is dedicated to the development of novel progenitor cell-based regenerative therapeutics to provide new treatment options to patients suffering from cardiovascular diseases like myocardial infarction or peripheral vascular diseases.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2006)
- Website: t2cure.de
- Phone: +49-69-7561 4687 0
Industries & Categories
Biotechnology, Genetics, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/t2cure-2869816 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.